IL1B and metabolic dysfunction-associated steatohepatitis: Likewise, in an HFD-induced nonalcoholic steatohepatitis (NASH) murine model, KMF attenuated hepatic injury by inhibiting neutrophil-mediated inflammation and reducing the production of TNF-α and IL-1β (69).